NDC 70771-1107-2 - Eletriptan hydrobromide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70771-1107
- Requested NDC
- 70771-1107-2
- Package NDCs from labels
- 70771-1107-3, 70771-1107-0, 70771-1107-2, 70771-1107-4, 70771-1107-6
- Manufacturer
- Zydus Lifesciences Limited
- Effective date
- 2024-11-28
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Eletriptan hydrobromide - Zydus Lifesciences Limited | Zydus Lifesciences Limited | 2024-11-28 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70771-1107-0 | Eletriptan hydrobromide | 1000 in 1 BOTTLE | TABLET, FILM COATED | 1000 | 7 | |
| 70771-1107-2 | Eletriptan hydrobromide | 10 in 1 BLISTER PACK | TABLET, FILM COATED | 10 | 7 | |
| 70771-1107-3 | Eletriptan hydrobromide | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | 7 | |
| 70771-1107-4 | Eletriptan hydrobromide | 10 in 1 CARTON | TABLET, FILM COATED | 10 | 7 | |
| 70771-1107-6 | Eletriptan hydrobromide | 1 in 1 CARTON | TABLET, FILM COATED | 1 | 7 | |
| 70771-1107-6 | Eletriptan hydrobromide | 6 in 1 BLISTER PACK | TABLET, FILM COATED | 6 | 7 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70771-1107 | ELETRIPTAN HYDROBROMIDE TABLET, FILM COATED [ZYDUS LIFESCIENCES LIMITED] | 7 | Current NDC, Legacy NDC, 6 package rows | 20241201_481ae7d4-9e57-424a-9d07-2920954b6ddc.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.